Paul Schoenhagen, MD Department of Radiology, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation
Steven E. Nissen, MD Department of Cardiovascular Medicine, The Cleveland Clinic Foundation
Address: Paul Schoenhagen, MD, Department of Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail schoenp1@ccf.org
The authors have indicated that they have received research support from the Pfizer, Merck, AstraZeneca, Sankyo, and Takeda corporations.
ABSTRACTIntravascular ultrasonography (IVUS) can precisely measure plaque burden and is being used to test new drug therapies. Other imaging tests may also prove useful to monitor treatment of atherosclerosis and identify populations at risk for coronary artery disease (CAD).
